Inari Medical Inc (NASDAQ:NARI) has a beta value of 0.93 and has seen 3.19 million shares traded in the last trading session. The company, currently valued at $4.66B, closed the last trade at $79.54 per share which meant it gained $0.09 on the day or 0.11% during that session. The NARI stock price is 0.05% off its 52-week high price of $79.50 and 53.82% above the 52-week low of $36.73. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.29 million shares traded. The 3-month trading volume is 1.51 million shares.
The consensus among analysts is that Inari Medical Inc (NARI) is Buy stock at the moment, with a recommendation rating of 2.80. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 2 out of 8 have rated it as a Hold, with 5 advising it as a Buy. 1 have rated the stock as Underweight. The expected earnings per share for the stock is -0.03.
Inari Medical Inc (NASDAQ:NARI) trade information
Sporting 0.11% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the NARI stock price touched $79.54 or saw a rise of 0.15%. Year-to-date, Inari Medical Inc shares have moved 55.81%, while the 5-day performance has seen it change 55.81%. Over the past 30 days, the shares of Inari Medical Inc (NASDAQ:NARI) have changed 55.72%. Short interest in the company has seen 3.66 million shares shorted with days to cover at 4.02.
Wall Street analysts have a consensus price target for the stock at $66, which means that the shares’ value could drop -20.52% from current levels. The projected low price target is $50.0 while the price target rests at a high of $86.0. In that case, then, we find that the current price level is -8.12% off the targeted high while a plunge would see the stock lose 37.14% from current levels.
Inari Medical Inc (NARI) estimates and forecasts
Figures show that Inari Medical Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 53.91% over the past 6 months, with this year growth rate of -684.62%, compared to 14.80% for the industry. Revenue growth from the last financial year stood is estimated to be 22.16%.
14 analysts offering their estimates for the company have set an average revenue estimate of 160.61M for the current quarter. 9 have an estimated revenue figure of 168.66M for the next ending quarter. Year-ago sales stood 132.09M and 143.19M respectively for this quarter and the next, and analysts expect sales will grow by 21.59% for the current quarter and 22.16% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 32.83% over the past 5 years.
NARI Dividends
Inari Medical Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Inari Medical Inc (NASDAQ:NARI)’s Major holders
Insiders own 8.53% of the company shares, while shares held by institutions stand at 96.55% with a share float percentage of 105.55%. Investors are also buoyed by the number of investors in a company, with Inari Medical Inc having a total of 344.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 8.36 million shares worth more than $402.71 million. As of 2024-06-30, BLACKROCK INC. held 14.4355% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 5.63 million shares as of 2024-06-30. The firm’s total holdings are worth over $271.03 million and represent 9.7152% of shares outstanding.
